Clinical Trials
33 trialsSafety and Efficacy of Venetoclax Combination With Decitabine(DEC3-VEN) in the Treatment of AML in the Adult
The Second Affiliated Hospital of Kunming Medical University
Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours
Shanxi Bethune Hospital
CAR-T CD19 for Acute Myelogenous Leukemia With t 8:21 and CD19 Expression
Sheba Medical Center
SCCLG-M5
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Cladribine Combined With G-CSF and Cytarabine as a Salvage Treatment in R/R ALL
The First Affiliated Hospital of Soochow University
Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL
Nanfang Hospital, Southern Medical University
Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS
The First Affiliated Hospital of Soochow University
Predictor2
Assistance Publique - Hôpitaux de Paris
Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma
Gilead Sciences
Dec+Flu+Bu Conditioning Regimen for Elderly AML in CR Undergoing Allo-HSCT
Nanfang Hospital, Southern Medical University
TPM Regimen (Thalidomide, Prednisone and Methotrexate) in LGLL
Institute of Hematology & Blood Diseases Hospital, China
AML18
Cardiff University
The Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in China
Shandong University
CD123/CLL1 CAR-T Cells for R/R AML (STPHI_0001)
Fujian Medical University
Decitabine Plus mBU/CY Preconditioning for Relapse/Refractory Acute Leukemia
Peking University People's Hospital
Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT
Nanfang Hospital, Southern Medical University
The Effect of G-CSF on MRD After Induction Therapy in Newly Diagnosed AML
Nanfang Hospital, Southern Medical University
Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML
Nanfang Hospital, Southern Medical University
Combination of BTK Inhibitor Overcomes Drug-resistance in Refractory/Relapsed FLT3 Mutant AML
Nanfang Hospital, Southern Medical University
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL
Nanfang Hospital, Southern Medical University
Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL
Nanfang Hospital, Southern Medical University
PTX-II
University of Guadalajara
Low Dose Decitabine + Modified BUCY Conditioning Regimen for High Risk Acute Myeloid Leukemia Undergoing Allo-HSCT
The First Affiliated Hospital of Soochow University
CCFMPCA
Fujian Medical University
DeGREE
Seoul St. Mary's Hospital
MSC-CY
National Research Center for Hematology, Russia
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
The First Affiliated Hospital of Soochow University
AML-19
European Organisation for Research and Treatment of Cancer - EORTC
Unrelated Double Umbilical Cord Blood Units Transplantation
Tehran University of Medical Sciences
Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents
University Hospital Muenster
Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion
Rambam Health Care Campus
IAPLSG04
Christian Medical College, Vellore, India